Sign up to save your podcasts
Or
Share From Trials to Practice: What's New and What's Next for Myeloma
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
From Trials to Practice: What's New and What's Next for Myeloma
Drs. Gurbakhash Kaur and Danai Dima discuss next-gen CAR T and bispecific therapies for myeloma, including agents for extramedullary disease and GPRC5D targets.
View all episodes
By Rahul Banerjee, MD
4.8
2626 ratings
Drs. Gurbakhash Kaur and Danai Dima discuss next-gen CAR T and bispecific therapies for myeloma, including agents for extramedullary disease and GPRC5D targets.
More shows like The HemOnc Pulse
View all
Making Sense with Sam Harris
26,373 Listeners
JAMA Editors' Summary
137 Listeners
Research To Practice | Oncology Videos
116 Listeners
The Hematologist
28 Listeners
OncoPharm
184 Listeners
VJHemOnc Podcast
2 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
369 Listeners
Blood Podcast
53 Listeners
The Curious Clinicians
372 Listeners
Healthcare Unfiltered
136 Listeners
ASTCT Talks
9 Listeners
Blood Cancer Talks
49 Listeners
Two Onc Docs
185 Listeners
Oncology Brothers: Practice-Changing Cancer Discussions
43 Listeners
WolverHeme Happy Hour
29 Listeners